Publications by authors named "Yeteng Mu"

Claim this Profile
C
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles.
Yuxuan Liu, Fuxu Yang, Zhimin Li, Ting Wang, Yeteng Mu

Front Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy.
Yeteng Mu, Xingang Guan

Curr Med Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered elastin-like polypeptide-based hydrogel delivering chemotherapeutics and PD-L1 antibodies for potentiated cancer immunotherapy.
Jinguang Chen, Meiying Cui, Lianping He, Yeteng Mu, Nannan Hu

J Mater Chem B· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Preparation and Tumor Targeting Analysis of Cell Membrane Nanovesicles Derived from Breast Cancer Cells].
Chong Guo, Fu-Xu Yang, Ye-Teng Mu, Nan-Nan Hu, Yu-Xin Fan

Sichuan Da Xue Xue Bao Yi Xue Ban· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis